Published in Arch Neurol on May 01, 1988
Guidelines for the diagnosis and management of individuals with neurofibromatosis 1. J Med Genet (2006) 4.23
Sex Is a major determinant of neuronal dysfunction in neurofibromatosis type 1. Ann Neurol (2014) 3.01
Malignant peripheral nerve sheath tumors (MPNST)--clinicopathological study and treatment outcome of twenty-four cases. World J Surg Oncol (2006) 2.58
Chromosome 17p deletions and p53 gene mutations associated with the formation of malignant neurofibrosarcomas in von Recklinghausen neurofibromatosis. Proc Natl Acad Sci U S A (1990) 2.52
MR imaging differentiation of benign and malignant peripheral nerve sheath tumors: use of the target sign. Pediatr Radiol (1997) 2.02
Molecular genetics of neurofibromatosis type 1 (NF1). J Med Genet (1996) 1.83
Noonan syndrome and clinically related disorders. Best Pract Res Clin Endocrinol Metab (2011) 1.82
Constitutional mismatch repair-deficiency syndrome: have we so far seen only the tip of an iceberg? Hum Genet (2008) 1.81
Sporadic and multiple neurofibromas in the head and neck region: a retrospective study of 33 years. Clin Oral Investig (2007) 1.62
Motor proficiency in children with neurofibromatosis type 1. Pediatr Phys Ther (2010) 1.61
Novel PMS2 pseudogenes can conceal recessive mutations causing a distinctive childhood cancer syndrome. Am J Hum Genet (2004) 1.58
Deletions spanning the neurofibromatosis 1 gene: identification and phenotype of five patients. Am J Hum Genet (1994) 1.56
Disorders of dysregulated signal traffic through the RAS-MAPK pathway: phenotypic spectrum and molecular mechanisms. Ann N Y Acad Sci (2010) 1.54
Breast cancer and other neoplasms in women with neurofibromatosis type 1: a retrospective review of cases in the Detroit metropolitan area. Am J Med Genet A (2012) 1.53
Malignant transformation of neurofibromas in neurofibromatosis 1 is associated with CDKN2A/p16 inactivation. Am J Pathol (1999) 1.52
Posterior fossa tumors in children with neurofibromatosis type 1 (NF1). Childs Nerv Syst (2010) 1.48
A RASopathy gene commonly mutated in cancer: the neurofibromatosis type 1 tumour suppressor. Nat Rev Cancer (2015) 1.40
Familial syndromes associated with intracranial tumours: a review. Childs Nerv Syst (2013) 1.38
Endocrine tumours in neurofibromatosis type 1, tuberous sclerosis and related syndromes. Best Pract Res Clin Endocrinol Metab (2010) 1.35
Pheochromocytoma and paraganglioma: understanding the complexities of the genetic background. Cancer Genet (2012) 1.34
Decreased bone mineral density in patients with neurofibromatosis 1. Osteoporos Int (2005) 1.33
Advances in the treatment of neurofibromatosis-associated tumours. Nat Rev Clin Oncol (2013) 1.26
Unravelling the genetic basis of variable clinical expression in neurofibromatosis 1. Hum Mol Genet (2009) 1.21
Growth dynamics of plexiform neurofibromas: a retrospective cohort study of 201 patients with neurofibromatosis 1. Orphanet J Rare Dis (2012) 1.17
Racial/Ethnic Differences in Pediatric Brain Tumor Diagnoses in Patients with Neurofibromatosis Type 1. J Pediatr (2015) 1.15
Cervical cord compression from plexiform neurofibromas in neurofibromatosis 1. J Neurol Neurosurg Psychiatry (2007) 1.14
Quantitative assessment of whole-body tumor burden in adult patients with neurofibromatosis. PLoS One (2012) 1.13
Assessment of benign tumor burden by whole-body MRI in patients with neurofibromatosis 1. Neuro Oncol (2008) 1.12
Quantification and anatomic distribution of choroidal abnormalities in patients with type I neurofibromatosis. Graefes Arch Clin Exp Ophthalmol (2005) 1.11
Survival in Malignant Peripheral Nerve Sheath Tumours: A Comparison between Sporadic and Neurofibromatosis Type 1-Associated Tumours. Sarcoma (2009) 1.10
Genetic and cellular evidence of vascular inflammation in neurofibromin-deficient mice and humans. J Clin Invest (2010) 1.09
Corkscrew retinal vessels in neurofibromatosis type 1: report of 12 cases. Br J Ophthalmol (2002) 1.08
Phase I trial of pegylated interferon-alpha-2b in young patients with plexiform neurofibromas. Neurology (2011) 1.08
Increased risk of breast cancer in women with NF1. Am J Med Genet A (2012) 1.07
Molecular diagnosis of neurofibromatosis type 1: 2 years experience. Fam Cancer (2007) 1.07
A 90 kb DNA deletion associated with neurofibromatosis type 1. J Med Genet (1990) 1.07
MR imaging of abdominopelvic involvement in neurofibromatosis type 1: a review of 43 patients. Pediatr Radiol (2004) 1.06
Elucidating the impact of neurofibromatosis-1 germline mutations on neurofibromin function and dopamine-based learning. Hum Mol Genet (2015) 1.05
Head and neck paragangliomas in von Hippel-Lindau disease and multiple endocrine neoplasia type 2. J Clin Endocrinol Metab (2009) 1.04
SPRED 1 mutations in a neurofibromatosis clinic. J Child Neurol (2010) 1.03
Large de novo DNA deletion in a patient with sporadic neurofibromatosis 1, mental retardation, and dysmorphism. J Med Genet (1992) 1.03
Generalized metabolic bone disease in Neurofibromatosis type I. Mol Genet Metab (2008) 1.02
Somatic neurofibromatosis type 1 (NF1) inactivation characterizes NF1-associated pilocytic astrocytoma. Genome Res (2012) 1.02
Modeling cognitive dysfunction in neurofibromatosis-1. Trends Neurosci (2013) 1.00
Differentiation between neurofibromas and malignant peripheral nerve sheath tumors in neurofibromatosis 1 evaluated by MRI. J Cancer Res Clin Oncol (2008) 1.00
Neurofibromatosis type 1 molecular diagnosis: what can NGS do for you when you have a large gene with loss of function mutations? Eur J Hum Genet (2014) 1.00
p.Arg1809Cys substitution in neurofibromin is associated with a distinctive NF1 phenotype without neurofibromas. Eur J Hum Genet (2014) 1.00
Nutraceuticals safety and efficacy in migraine without aura in a population of children affected by neurofibromatosis type I. Neurol Sci (2013) 0.99
Schwannomatosis involving peripheral nerves: a case report. J Korean Med Sci (2006) 0.99
Response to imatinib in KIT- and PDGFRA-wild type gastrointestinal stromal associated with neurofibromatosis type 1. Dig Dis Sci (2006) 0.98
Plexiform schwannoma of the forearm. Skeletal Radiol (2003) 0.98
Evaluation of intratumoural heterogeneity on ¹⁸F-FDG PET/CT for characterization of peripheral nerve sheath tumours in neurofibromatosis type 1. Eur J Nucl Med Mol Imaging (2012) 0.96
Mortality associated with neurofibromatosis type 1: a study based on Italian death certificates (1995-2006). Orphanet J Rare Dis (2011) 0.96
Genetic predisposition to peripheral nerve neoplasia: diagnostic criteria and pathogenesis of neurofibromatoses, Carney complex, and related syndromes. Acta Neuropathol (2011) 0.95
Neurocutaneous syndrome: a prospective study. Indian J Dermatol (2011) 0.95
Neurofibromatosis type 1 (NF1): a protein truncation assay yielding identification of mutations in 73% of patients. J Med Genet (1998) 0.95
Concomitant compostite adrenal phoechromocytoma, multipte gastric stromal tumours and pseudohermaphrodism in a patient with von Recklinghausen's disease. Int Semin Surg Oncol (2006) 0.94
Multiple meningiomas of the central nervous system without the stigmata of neurofibromatosis. Clinical and therapeutic study. Neurosurg Rev (1997) 0.94
Autism spectrum disorder profile in neurofibromatosis type I. J Autism Dev Disord (2015) 0.93
Does cognitive impairment explain behavioral and social problems of children with neurofibromatosis type 1? Behav Genet (2010) 0.93
Oncologic manifestations of neurofibromatosis type 1 in Korea. J Korean Surg Soc (2012) 0.93
Oral soft tissue alterations in patients with neurofibromatosis. Clin Oral Investig (2011) 0.92
The NF1 gene revisited - from bench to bedside. Oncotarget (2014) 0.91
Diagnostic criteria, specific mutations, and genetic predisposition in gastrointestinal stromal tumors. Appl Clin Genet (2010) 0.91
C-->U editing of neurofibromatosis 1 mRNA occurs in tumors that express both the type II transcript and apobec-1, the catalytic subunit of the apolipoprotein B mRNA-editing enzyme. Am J Hum Genet (2001) 0.91
A case report of a malignant peripheral nerve sheath tumor of the oral cavity in neurofibromatosis type 1. Case Rep Otolaryngol (2012) 0.91
Monozygotic twins discordant for neurofibromatosis 1. Am J Med Genet A (2010) 0.91
Incidence and mortality of neurofibromatosis: a total population study in Finland. J Invest Dermatol (2014) 0.91
Clinical variability of type 1 neurofibromatosis: is there a neurofibromatosis-Noonan syndrome? J Med Genet (1992) 0.90
Pediatric neurofibromatosis 1 and parental stress: a multicenter study. Neuropsychiatr Dis Treat (2014) 0.90
Patterns of associations of clinical features in neurofibromatosis 1 (NF1). Hum Genet (2002) 0.89
Toward a survey of somatic mutation of the NF1 gene in benign neurofibromas of patients with neurofibromatosis type 1. Am J Hum Genet (2000) 0.89
Paragangliomas/Pheochromocytomas: clinically oriented genetic testing. Int J Endocrinol (2014) 0.89
A case of neurofibromatosis and multiple sclerosis. Neurol Sci (2010) 0.89
Carbon dioxide laser treatment of cutaneous neurofibromas. Dermatol Ther (Heidelb) (2012) 0.88
An epidemiological, clinical and genetic survey of neurofibromatosis type 1 in children under sixteen years of age. Ulster Med J (2008) 0.88
Neurofibromatosis type 1 in childhood: correlation of MRI findings with intelligence. J Neurol Neurosurg Psychiatry (1995) 0.87
Somatic deletion of the NF1 gene in a neurofibromatosis type 1-associated malignant melanoma demonstrated by digital PCR. Mol Cancer (2006) 0.87
Linkage analysis of neurofibromatosis type I, using chromosome 17 DNA markers. Am J Hum Genet (1989) 0.87
Combined hamartoma of the retina and retinal pigment epithelium associated with neurofibromatosis type-1. Int Ophthalmol (2001) 0.87
Surgical correction of severe dystrophic neurofibromatosis scoliosis: an experience of 32 cases. Eur Spine J (2010) 0.86
Neurofibromatosis presenting with a cherubism phenotype. Eur J Pediatr (2006) 0.86
Neuropsychological outcome in children with optic pathway tumours when first-line treatment is chemotherapy. Br J Cancer (2003) 0.86
Neurofibromatosis type 1 and type I Chiari malformation: an unusual association. Childs Nerv Syst (1996) 0.86
Piebaldism with neurofibromatosis type I: a familial case. Ann Dermatol (2014) 0.86
Multiple schwannomas: report of two cases. Eur Spine J (2007) 0.86
Frequent EGFR Positivity and Overexpression in High-Grade Areas of Human MPNSTs. Sarcoma (2008) 0.86
No correlation between NF1 mutation position and risk of optic pathway glioma in 77 unrelated NF1 patients. Hum Genet (2016) 0.86
Ophthalmological manifestations in segmental neurofibromatosis type 1. Br J Ophthalmol (2004) 0.85
Gyrification, cortical and subcortical morphometry in neurofibromatosis type 1: an uneven profile of developmental abnormalities. J Neurodev Disord (2013) 0.85
Clinico-pathological and biomolecular findings in Italian patients with multiple cutaneous neurofibromas. Hered Cancer Clin Pract (2011) 0.85
Pediatric brain MRI in neurofibromatosis type I. Eur Radiol (2004) 0.85
Unidentified bright objects on brain MRI in children as a diagnostic criterion for neurofibromatosis type 1. Pediatr Radiol (2008) 0.85
A genetic study of neurofibromatosis type 1 (NF1) in south-western Ontario. II. A PCR based approach to molecular and prenatal diagnosis using linkage. J Med Genet (1993) 0.85
An unusual pediatric case with neurofibromatosis and systemic lupus erythematosus. Rheumatol Int (2011) 0.85
Rare and unusual endocrine cancer syndromes with mutated genes. Semin Oncol (2010) 0.84
Retinal microvascular abnormalities overlying choroidal nodules in neurofibromatosis type 1. BMC Ophthalmol (2014) 0.84
Evidence of increased bone resorption in neurofibromatosis type 1 using urinary pyridinium crosslink analysis. Pediatr Res (2008) 0.84
Diffuse large B cell lymphoma presenting as Horner's syndrome in a patient diagnosed with neurofibromatosis type 1: a case report and review of the literature. J Med Case Rep (2012) 0.84
18F-FDG PET/CT for detection of malignant peripheral nerve sheath tumours in neurofibromatosis type 1: tumour-to-liver ratio is superior to an SUVmax cut-off. Eur Radiol (2013) 0.84